- About Us
- Nano-Social Network
- Nano Consulting
- My Account
2 1/2 day short course the University of Wisconsin
Industrial Short Course
May 16-18, 2005
Nanotechnology along with biotechnology and bioinformatics constitute the basis of 21st Century therapeutics with joint ventures and collaborations between academia, government and industry. Advances in Nanotechnology have indeed revolutionized our thinking from research, engineering and business perspectives. It is the purpose of this course to provide the participants with the state-of-art in nanoscience and nanotechnology as applied to drug discovery, delivery and development.
Nanotechnology for biotech and pharmaceutical applications has progressed from the concept stage to commercialization. Improving the develop-ability of new molecules and the efficacy and delivery of existing drugs is the key to a successful future. In this course, an overview and key highlights of nanotechnology and its diverse applications will be featured first along with an overview of nanoscience and nanotechnology programs and initiatives at the NIH.
The primary objective in this course is to upgrade the knowledge of pharmaceutical personnel, who can then be of greater value to their respective firms. Students will work closely with the faculty members to allow for optimum dialogue and discussion. To allow for maximum faculty-student interaction, the enrollment will be limited to 30 registrants. As with all UW School of Pharmacy programs, it is designed to be practical and applicable to participants' work environments.
The general session of the course will include a series of topics in nanobiotechnology, such as nanobiosensors and nanogenomics and their impact to drug discovery. Polymer- and lipid-based micro-and nanostructures will be discussed next and illustrated with case studies where these systems have been successfully used throughout the drug development value chain.
Upon completion of the course, the learner should be able to:
For more information, visit the course webpage.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
AIM Photonics Welcomes Coventor as Newest Member: US-Backed Initiative Taps Process Modeling Specialist to Enable Manufacturing of High-Yield, High-Performance Integrated Photonic Designs March 16th, 2017
Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016
Argon is not the 'dope' for metallic hydrogen March 24th, 2017